Kelly Timothy P 4
4 · Caribou Biosciences, Inc. · Filed Jan 9, 2024
Insider Transaction Report
Form 4
Kelly Timothy P
Chief Technology Officer
Transactions
- Award
Option to purchase Common Stock
2024-01-08+300,000→ 300,000 totalExercise: $5.74Exp: 2034-01-07→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option shall vest on January 1, 2025, and the remaining shares subject to the option shall vest monthly thereafter (1/48 of the shares per month for the 36 months following the one-year cliff), subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.